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  27	
Abstract  28	
Purpose 29	
UVA/riboflavin induced corneal cross-linking is a common therapeutic approach used to 30	
prevent progression in keratoconus. However, there is limited understanding of how changes 31	
to the mechanical behavior in cross-linked corneas relate to changes in the corneal 32	
ultrastructure. The aim of this study was to determine these relationships and, by so doing, 33	
provide a reference against which future modifications to cross-linking approaches may be 34	
compared. 35	
Methods 36	
Porcine corneas were treated following the “Dresden” protocol, the current gold standard for 37	
clinical treatment, consisting of dropwise application of 0.1% riboflavin in 20% dextran 38	
followed by 30 minutes of UVA irradiation. The effect of crosslinking was assessed using 39	
uniaxial tensile testing, transmission electron microscopy, and Fourier Transform Infrared 40	
Spectroscopy with results compared against corneas treated with each of the treatment 41	
solution components individually 42	
Results  43	
Data revealed that UVA/riboflavin cross-linked corneas displayed 28±17% increase in the 44	
material tangent modulus compared with dextran treatment alone, and altered collagen 45	
architecture within the first 300 µm of stromal depth consisting of 5% increase in the 46	
thickness of collagen fibrils, no significant changes to interfibrillar spacing, and an 8% to 47	
12% decrease in number of fibrils per unit area. Fourier Transform Infrared Spectroscopy 48	
confirmed formation of interfibrillar bonds (p=0.012) induced by UVA mediated 49	
cross-linking. 50	
Conclusions 51	
Our data support a model wherein collagen fibril diameter and structural density are 52	
fundamental parameters in defining tissue stiffening following UVA/riboflavin corneal 53	
cross-linking, and provide benchmarks against which modifications to the Dresden 54	
cross-linking protocol can be evaluated. 55	
 56	
Precis 57	
This paper provides the connection between ultrastructural and mechanical properties 58	
changes induced by the current gold standard UVA/riboflavin cross-linking protocol. It 59	
provides a benchmark against which future protocol modifications can be evaluated. 60	
Introduction   61	
Keratoconus is a corneal thinning disease which results in a focally reduced corneal radius of 62	
curvature, abnormal wavefront aberrations, and a localised reduction in corneal thickness and 63	
stiffness, these aberrations lead to a decline in visual function which ultimately may require 64	
corneal transplantation1. Corneal cross-linking with riboflavin and UVA is an established 65	
treatment for progressive keratoconus and currently is the only therapeutic approach that is 66	
capable of significantly altering disease progression2 available for many years in Europe, this 67	
treatment option has been recently approved by the US Food and Drugs Administration for 68	
use in United States2.. The so-called “Dresden” or “standard” protocol is the current standard 69	
approach for corneal cross-linking for keratoconus; consisting of 30 minutes exposure to 70	
3mW fluence (5,4 mJ/cm2) following 30 mins soaking in 0.1% riboflavin	3.  71	
 72	
The Dresden protocol involves topical dosing of the cornea, following epithelial removal, 73	
with 0.1% riboflavin in 20% dextran for 30 minutes, then exposure to ultraviolet light over a 74	
30 minute period. This rationale behind this approach is that photo-polymerisation, in the 75	
presence of the photosensitizer riboflavin, leads to creation of chemical bonds between 76	
substrates within the corneal stroma, including between collagens and proteoglycans, and 77	
other stromal proteins3-5. The effects of these induced cross-links have been variously 78	
reported as increases in tissue stiffness, resistance to enzymatic digestion, changes to 79	
ultrastructure and altered swelling behaviour6-9.	 However, these studies have generally 80	
evaluated the overall effects of full cross-linking protocol without separating the contribution 81	
of individual aspects of the treatment and there are some differences in outcome 82	
reported5,6,10,11.  83	
 84	
Mechanical properties of biological tissues are largely dependent upon the intertwining of 85	
collagen fibrils, linked lamina layers and interfibrillar spacing12-14. Therefore, the efficacy of 86	
the Dresden corneal cross-linking protocol is believed to be dependent on changes to the 87	
mechanical properties of the tissue induced through modifying the characteristics of collagen 88	
fibrils within the cornea, and the induction of intrafibrillar bonds, with the overall level of 89	
effect being dependent on treatment depth15,16. Previous studies have attempted to evaluate 90	
mechanical properties and the effective cross-linking penetration depth by specifically 91	
examining anterior and posterior corneal layers 9,17,18. These studies demonstrated that the 92	
collagen cross-linking effect is predominantly located within anterior stroma but did not 93	
specify the parameters that may be involved in determining and defining the amount of the 94	
tissue stiffening induced. Indeed, the relationship between the mechanical behaviour of 95	
cross-linked cornea and its ultrastructure is poorly explored, and the specific contribution of 96	
the dextran within the riboflavin solution has not been reported18,19.  97	
 98	
numerous modifications to the Dresden protocol are being trialed in clinical settings therefore 99	
defined knowledge of the effect of the current treatment regime is needed to provide a 100	
benchmark against which these modifications can be compared and moreover for rationale 101	
design of alternative approaches. The present study aimed to improve this understanding by 102	
systematically investigating the role of dextran and the effect of riboflavin and UVA 103	
cross-linking in inducing mechanical and ultrastructural changes in the porcine cornea. 104	
  105	
Materials and methods 106	
Cross-linking Procedure and Experimental Design  107	
Fresh porcine eyes were collected from an abattoir, washed with phosphate-buffered saline 108	
(PBS) (Sigma, Dorset, United Kingdom), the central corneas excised and the corneal 109	
epithelium removed. To control for inter-animal variation, each cornea was cut into two 110	
segments in a superior-inferior fashion with one half being used as the test sample and the 111	
second for the control treatment (Fig. 1). 112	
  113	
The treatment groups were assigned into groups as follows: Group 1 (PBS vs. PBS): 6 114	
corneas; each half cornea was topically treated with PBS in 3 minute intervals for 1 hour. 115	
used to examine the intrinsic differences between the two segments of each porcine cornea. 116	
Group 2 (PBS vs. Riboflavin + PBS): 6 corneas; each corneal segment was topically treated 117	
in 3-minute intervals for 1 hour with either PBS or 0.1% riboflavin (Sigma) prepared in PBS. 118	
Group 3 (PBS vs. Riboflavin + Dextran): As for Group 2, except that the riboflavin was 119	
prepared in 20% dextran (Sigma).  Group 4 (Dextran vs. Riboflavin + Dextran + UVA): 10 120	
corneas; one half treated following the conventional Dresden protocol3, the anterior surface 121	
of the corneas were treated with 5ml of 0.1% riboflavin in 20% dextran every 3-minutes 122	
intervals for 30 minutes, followed by UVA (370nm) illumination at 3 mW/cm2 (Opto XLink, 123	
Mehra Eyetech Pvt Ltd, Delhi, India) for a further 30 minutes. Topical dosing of riboflavin 124	
with dextran drops was continued every 3 minutes manner during the UVA irradiation (for 125	
full cross-linking details following the standard convention, see table 1)20. Cross-linked 126	
corneas were compared to fellow segments treated with 20% dextran only.  127	
 128	
Following treatment, the corneal tissues were dissected for mechanical testing and for 129	
ultrastructural analysis (Fig 1). 130	
 131	
Tensile Testing 132	
Corneal stiffness was examined using a uniaxial tensile tester, Instron 3366 machine (Instron 133	
Engineering Corp., MA, USA), equipped with a 10N load cell. Two strips (3mm width x 134	
6mm length) cut in the superior-inferior direction at the central cornea were inserted 135	
vertically into custom designed clamps and the protocol set to apply a maximum loading 136	
stress of 0.125 MPa, slightly above the stress expected under an intraocular pressure of 80 137	
mmHg21. A constant extension of 1 mm/min was applied and the corresponding stress 138	
(applied force divided by cross-sectional area) and strain (extension over original length) 139	
measured continuously. Five conditioning cycles21, with four-minute recovery periods 140	
between each two cycles, were performed. The tangent modulus (Et), the gradient of a 141	
tangent of the stress-strain behavior pattern, was calculated at different stress levels to derive 142	
the overall stiffness of the tissue22,23.  143	
 144	
Transmission electron microscopy 145	
Transmission electron microscopy (TEM) was performed as described previously6. Briefly, 146	
the specimens were isolated from the central regions of cornea (Fig 1) and fixed overnight 147	
with 2.5% glutaraldehyde (TAAB Laboratories Equipment Ltd, Reading, UK) in 0.1% tannic 148	
acid. Thereafter, specimens were dissected into 1mm x 2mm blocks and incubated with 4% 149	
osmium (TAAB), followed by serial dehydration through an acetone gradient (30%, 50%, 150	
70%, 90%, 100%)(Sigma). Specimens were then infiltrated and embedded in medium resin 151	
(TAAB) and ultrathin 70 nm-thickness sections cut using a diamond knife microtome and 152	
collected onto 200 mesh copper grids (Ted Pella, Inc., CA, USA). Sections were examined 153	
using a Tecnai G2 spirit BioTWIN Transmission electron microscope (FEI Company, OR, 154	
USA) operated at 120kV and 60k-fold magnification with a CCD camera. Tissues were 155	
sampled at five depth intervals from top of the anterior stroma 0-50µm, 80-150µm, 156	
200-250µm, 300-350µm, 400-450µm. 157	
 158	
Collagen fibrils in longitudinal, frontal and oblique profiles were observed in TEM images; 159	
only those in frontal profiles were used for quantitative analysis with analyses performed 160	
using Fiji software (National Institutes of Health, Bethesda, MA, USA). Ultrastructural 161	
parameters evaluated were; i) mean diameter of collagen fibrils ii) interfibrillar spacing and 162	
iii) number of fibrils per unit area. For i) circular spots in frontal profiles were isolated, 163	
exported and diameters measured. ii) The calculation of interfibrillar spacing was generated 164	
from equation (1) while assuming that the collagen fibrils were evenly distributed.  165	
               	R + D = 𝐴 𝑁                                 (1) 166	
Here R was defined as interfibrillar spacing (nm), D as mean diameter of collagen fibrils 167	
(nm), A as the area of selected zone of measurement (nm2), N as the number of fibrils 168	
(circular spots) within the selected zone. iii) fibrils per unit area was determined by randomly 169	
localising a window of fixed unit size (300 x 300 dpi) and the number of circular spots 170	
counted.  171	
The distribution curve of collagen fibrils was assessed with a bespoke code using MATLAB 172	
2016b (The MathWorks Inc., Natick, MA, USA). Original images were converted to binary 173	
using adaptive thresholding and a custom designed collagen fibril detection system, using the 174	
Circular Hough Transform (CHT) based algorithm 24,25, was established to analyse the radius 175	
of circular objects in frontal profiles of TEM images. Distribution curves were generated by 176	
plotting the frequency in 2nm increments against fibril radius.  177	
 178	
Fourier Transform Infrared (FTIR) Absorption Spectroscopy  179	
Fresh porcine corneas were treated with either PBS, 0.1% riboflavin in 20% dextran or the 180	
full Dresden protocol (6 per group), lyophilized for 3 days, then FTIR spectra measured using 181	
a Nicolet 6700 FTIR spectrometer (Thermo Scientific, MA, USA) with a attenuated total 182	
reflection (ATR) module. 64 accumulative scans were taken with a resolution of 4 cm-1 183	
between 800 cm-1 to 4000 cm-1. Data was collected using OMNIC software (Thermo 184	
Scientific, MA, USA). Analyses of FTIR spectra of each condition were obtained with a 185	
combination of four spectral intervals [ν(C=O) absorption of amide I (1,680–1,630 cm−1), 186	
δ(NH2) absorptions of amide II (1,570–1,515 cm−1), ν(C–N) absorptions of amide III (1,350–187	
1,200 cm−1), and ν(C–O) absorptions of carbohydrate moieties (1,150–1,000 cm−1)]. Area 188	
under the curve at each interval was analyzed using KnowItAll® ID Expert™ (Bio-Rad, CA, 189	
USA). 190	
 191	
Statistical Analysis  192	
Results for mechanical, ultrastructural and FTIR spectra analyses are presented as means ± 193	
standard deviation (SD) and statistical significance calculated using one-way analysis of 194	
variance (ANOVA) with Turkey’s HSD post-hoc tests. The Mann-Whitney U test (two-tailed) 195	
was used for analyzing the statistical difference of the distribution curves, and significance 196	
differences accepted where p < 0.05. 197	
     198	
Results 199	
UVA/riboflavin treatment and dextran mediated dehydration both contribute to 200	
mechanical property changes in corneal cross-linking. 201	
In order to isolate the effect of the individual components of UVA/riboflavin crosslinking 202	
procedure, uniaxial tensile experiments and transmission electron microscopy were 203	
conducted on a set of porcine split into paired comparison groups. To account for 204	
inter-animal variability, each cornea was cut in two and one half treated with the treatment 205	
and compared against the control (Fig 1), tensile measurements and ultrastructural analyses 206	
were performed on the same cornea). Comparison groups were: PBS vs. PBS, riboflavin in 207	
PBS vs. PBS, riboflavin in 20% dextran vs. PBS and riboflavin in 20% dextran+UVA vs. 208	
20% dextran (Fig 1).  209	
 210	
The tangent modulus (Et) versus stress (s) for each corneal strip was determined and the 211	
overall stiffening effect indicated by the ratio of the tangent modulus (Etexperimental /Etcontrol). 212	
Comparisons concentrated on tangent modulus ratios at a stress of 0.03MPa, which is 213	
equivalent to a physiological intraocular pressure (IOP) of around 25mmHg21. As expected, 214	
no significant differences were observed where both corneal segments were treated 215	
identically with PBS, confirming the validity of our intra-eye control system (Et experimental PBS 216	
vs. Et control PBS: 1.36±0.32 vs. 1.43±0.30 at 0.03MPa, respectively, p = 0.075, Figs 2A and 2B, 217	
S1 Table). Riboflavin in PBS treatment also caused no stiffening (riboflavin in PBS 218	
1.45±0.15 vs. PBS 1.38±0.17, p = 0.448, Figs 2C, S1 Table). However, the riboflavin in 20% 219	
dextran group displayed a 13±9% tangent modulus increase compared to their internal PBS 220	
control (riboflavin in dextran: 1.52±0.17 vs. PBS 1.34±0.18, p = 0.011, Figs 2D, S1 Table). 221	
Comparing the effect of the full Dresden crosslinking protocol to the effect of dextran 222	
treatment alone, we observed a 28±17% increase in tangent modulus in the Dresden treated 223	
corneal segments (riboflavin in dextran + UVA 2.09±0.17 vs. dextran 1.62±0.18 p = 224	
5.67E-05, Figs 2E, S1 Table).  225	
 226	
The differences observed with dextran alone were somewhat surprising however, upon 227	
comparing the tissue thicknesses following treatments, we observed statistically significant 228	
reduced thicknesses in the dextran treated samples compared with their PBS controls, 229	
indicative of dehydration (mean thickness riboflavin in dextran 0.79±0.04 mm, PBS 230	
1.05±0.39 mm, p = 1.39x10-6)(Fig 2F and S1 Table). Correcting the tangent modulus 231	
readings with these thickness measurements removed the apparent dextran effects, whereas 232	
residual stiffening effect was still observed in the Dresden protocol treated samples after 233	
correction (Fig 2G). Together these data demonstrate that dextran treatment alone causes 234	
dehydration and therefore an apparently increased stiffening, whereas UVA exposed 235	
riboflavin treated corneas exhibit further increased stiffening beyond that caused by the 236	
dextran treatment alone. 237	
 238	
UVA/riboflavin treatment causes depth dependent changes to collagen fibril 239	
ultrastructure.  240	
Next we measured changes to the collagen ultrastructure of specimens, measured at five 241	
different depth intervals using TEM (S1 Fig, Fig. 2A; representative images at 80-150mm) 242	
and the obtained images used to determine collagen fibril diameter (Fig 2B), interfibrillar 243	
spacing and fibril number per unit area (density)(S2 Table). The overall morphologies of the 244	
collagen ultrastructure did not change following PBS or riboflavin in PBS treatment in the 245	
absence of UV (S1 Fig, S2 Table). However, the dextran treatment led to significantly thinner 246	
collagen fibrils (Fig 3A), as well as reduced interfibrillar spacing and denser packing at all 247	
depth intervals compared to its PBS control (S1 Fig). As dextran also causes loss of tissue 248	
hydration we used a mathematical method to correct for dehydration effects, in order to 249	
identify the true structural changes26. The relationship between thickness (T) and hydration 250	
(H) was modelled using the equation T = 0.2*e^(0.33*H) which has been shown to be 251	
effective for these types of calculation26. The reduction in thickness followed an exponential 252	
decrease in tissue hydration, which we used to calculate the hydration state of the tissues and 253	
therefore calculate swelling factors at each depth interval (S3 Table). Analysis of fibril 254	
diameter at each depth interval revealed that although, in the uncorrected data, dextran 255	
treatment caused a reduction in the frequency of large collagen fibrils compared to PBS 256	
treatment (Figs 3B; 80-150mm, S2 Table and S3 Table), when correction for swelling factors 257	
was included, no significant differences were detected (Fig 3B and S2 Fig), indicating that 258	
dextran treatment alone has no effect on collagen fibril diameter.  259	
 260	
In analyzing the effect of the Dresden UVA/riboflavin crosslinking protocol on corneal 261	
ultrastructure, both segments within our intra-eye comparisons were treated with dextran 262	
therefore any residual difference between the internal controlled comparison groups reflected 263	
a true effect of the crosslinking procedure. Analysis revealed a small but statistically 264	
significant increase in collagen fibril diameter in the cross-linked group at 80-150µm (5±2%, 265	
p<0.01) and 200-250µm depths (6±3%, p<0.01)) with no differences observed at any other 266	
depth intervals (Figs 4C and 4D, S2 Fig). No statistical differences in interfibrillar spacing 267	
between treatments were observed at any depths (Fig 4E), however the Dresden protocol 268	
caused a decrease in the number of fibrils per unit area in the anterior 250µm of the tissue 269	
(0-50µm 6±5%, p<0.05; 80-150µm 11±7%, p<0.01; 200-250µm 11±5%, p<0.01) (F5 and S2 270	
Table). Together these data indicate that the UVA crosslinking procedure creates relatively 271	
small, depth-localized changes to the collagen ultrastructure. 272	
 273	
Individual ultrastructural measurements are insufficient to predict mechanical changes. 274	
As we had performed the tangent modulus and ultrastructural measurements upon the same 275	
eye (Fig 1), we were able to directly compare the values obtained (Fig 5). Note comparisons 276	
were made between mechanical outcomes measured at 0.03MPa stress and structural 277	
parameters were determined from tissues in relaxed states. Collagen fibril diameter at 278	
80-150µm, intrafibril spacing increases, and collagen fibril density decreases each displayed 279	
correlation with tangent modulus increases across the test population (diameter; r2 =0.23, Fig. 280	
5A, spacing r2= 0.39, Fig. 5B, density r2=0.52, Fig. 5C). When percentage change on an 281	
individual eye basis was plotted, the none of the individual ultrastructural parameters were  282	
independently indicative of the overall tissue stiffness (Fig. 5D). However, when considered 283	
in combination, the ultrastructural measurements performed better, with a positive correlation 284	
of 0.177 (collagen fibril diameter + fibril density - interfibrillar spacing, Fig. 5E).  285	
 286	
Fourier Transform Infrared Spectroscopy Reveal the Formation of New Amide Bonds 287	
in Cross-linked Corneas 288	
To assess the detailed chemical reactions and the conversion of chemical bonds within the 289	
cornea tissue after UVA/riboflavin cross-linking, Fourier Transform Infrared Spectroscopy 290	
measurements were performed on corneas treated with either PBS, riboflavin+dextran or 291	
riboflavin+dextran+UVA (Fig 6A and B). The relevant characteristic bands were; amide I 292	
C=O stretching vibration (1,680–1,630 cm-1), amide II NH2 bending vibration (1570-1515 293	
cm-1), amide III C-N stretching vibration (1,350–1,200 cm-1),	 and C-O bond stretching 294	
vibration (1,150–1,000 cm−1). The area under each band was calculated, and the deformation 295	
vibrations of CH2 (1,485–1,360 cm−1) used as an internal standard to determine the intensity 296	
ratios (Fig 6C, S4 Table). These analyses revealed significant increases in the C-O stretch 297	
peak,  decreased C-N stretch and increased NH2 deformation following crosslinking (Fig 298	
6C). Plotting the ratio of C-N stretch to NH2 deformation suggests that the decrease 299	
intensities of amide II infrared absorption bands are likely to be accompanied by an increase 300	
in the formation of amide III bonds (riboflavin+dextran+UVA 2.5±0.5 compared to PBS 301	
1.7±0.3, and riboflavin+dextran 1.8±0.2 Fig 6D, S4 Table).  302	
  303	
Discussion  304	
In this study, we have characterized how corneal mechanical properties relate to 305	
ultrastructural changes following Dresden protocol treatment, and identified the contribution 306	
of the different components of the protocol to observed effects. Specifically, our data 307	
demonstrate that the increases in corneal stiffness measured following Dresden protocol 308	
treatment arise from combination of dextran-mediated dehydration along with 309	
UVA/riboflavin induced new bond formation and depth-dependent increases in collagen fibril 310	
diameter. 311	
Tissue stiffness is considered as a combination of the internal geometry of the tissue and the 312	
properties of the material itself. Therefore, although our data indicate that almost half of the 313	
measured stiffening effect of the Dresden protocol comes from the dextran component of the 314	
protocol, these effects can be explained by dehydration effects. However, we did observe an 315	
increase in C-O stretching force in the riboflavin in dextran treated corneas compared with 316	
controls indicating that dextran does itself induce collagen changes. A potential explanation 317	
for these new bonds is that the dextran induced dehydration increases the swelling pressure of 318	
tissue and therefore the resistance pressure of proteoglycan matrix26,27, giving rise to 319	
intermolecular forces. These dextran and dehydration effects could help explain some of the 320	
apparently contradictory reports in the literature 5,6,10,11. Interestingly tissue hydration states 321	
have been reported to affect the efficacy of cross-linking treatment27, therefore, hydration 322	
states and the osmolarity of the riboflavin solutions could be important factors to consider in 323	
protocol modifications. 324	
 325	
Our FTIR data revealed significant changes in C-O stretching force and conversion rate of 326	
amide bonds following the full Dresden protocol. Lysine-based cross-links following 327	
UVA/riboflavin cross-linking have previously been postulated but not been found 328	
chemically3,28 but it has been proposed that cross-links form through endogenous carbonyl 329	
groups including imidazole formation29. Our data support a model where the increased 330	
swelling pressure and the involvement of endogenous carbonyls (allysine) leads to the new 331	
bond formation22. This leads to a broader mechanism where UVA/riboflavin induced 332	
intra-fibril bonds. presenting as thickened collagen fibrils and less dense overall structure and 333	
drive the increased tissue mechanical strength and resistance to dehydration (Fig. 7).  334	
 335	
It should be noted, however, that the ultrastructural changes we measured do not fully 336	
account for the mechanical effects suggesting that collagen fibril diameter and spacing are 337	
not the only aspects of stromal biology affected by UVA/riboflavin crosslinking. Effects  338	
upon other stromal proteins and particularly the interactions of collagen with proteoglycans, 339	
could be contributing to the stiffening. Proteoglycans within the corneal stroma have been 340	
proposed to play a pivotal role in regulating the fibril-fibril spacing and 341	
hydration-dehydration properties30, however, the dehydration induced decrease in interfibril 342	
spacing has prevented us from being able to determine the sole effect of cross-linking on 343	
proteoglycans within our experimental system.   344	
 345	
Understanding the stabilization mechanism of UVA/riboflavin cross-linking is clinically 346	
relevant when evaluating modifications to the Dresden protocol and developing optimal 347	
protocols or new keratoconus treatments. This study establishes the standards in terms of 348	
mechanical, chemical and structure/biological changes induced by the Dresden protocol	and	349	
therefore	provides	the	baseline	against	which	modifications	can	be	judged.	350	
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  448	
Figure legends 449	
Fig 1. Experimental scheme. Each cornea was cut into two segments in a superior-inferior 450	
fashion. The right-hand segment was used as an experimental segment, while the left-hand 451	
segment was used as its corresponding control. Four experimental groups were designed, 452	
Group 1: PBS vs. PBS; Group 2: PBS vs. riboflavin+PBS; Group 3: PBS vs. 453	
riboflavin+dextran; Group 4: dextran vs. riboflavin+dextran+UVA. After each treatment, 454	
specimens were dissected and processed for tensile testing (green hollow rectangle) and TEM 455	
(red hollow rectangle). S: superior; I: inferior.  456	
 457	
Fig 2. The tangent modulus (Et) versus stress (s) behaviour and ratio of tangent 458	
modulus of paired samples. (A) The tangent modulus versus stress behavior of right-hand 459	
corneal flaps versus left-hand flaps from 6 are plotted. Both flaps were identically treated by 460	
soaking in PBS. The ratio of tangent modulus between (B) PBS versus PBS (n=6), (C) 461	
riboflavin in PBS versus PBS (n=6), (D) riboflavin in 20% dextran versus PBS (n=6_, (E) 462	
riboflavin in 20% dextran+UVA exposure versus 20% dextran only (n=10). Values from 463	
each individual cornea pair tested are indicated by grey lines. Average stiffening ratio ± 464	
standard deviation are indicated by the bold line and error bars. The red dash line represented 465	
the value of 1; i.e. no difference between paired samples. Gray shaded region in A-E plots 466	
represents 0.03MPa. (F) average thickness measurement of each comparison group after 467	
treatment. (G) the stiffening ratio at 0.03MPa with and without correction for tissue thickness 468	
changes. Values in F and G denote mean ± standard deviation (SD). * p value of < 0.05, ** 469	
p<0.01.   470	
 471	
Fig 3. Transmission electron microscopy (TEM) images of porcine corneas imaged at 472	
depth of 80-150µm (A) Representation TEM images of PBS, riboflavin in dextran, and 473	
dextran only and riboflavin/dextran/UVA cross-linked corneas. Bar 500nm.An area of 300 x 474	
300 dpi (yellow dash-square) is shown at higher magnification in (B) with example of the 475	
measurement of the area and density of collagen fibrils.  476	
 477	
Fig 4. Measurement of ultrastructural parameters and collagen fibril distribution at 478	
different depth intervals. (A) Mean collagen fibril diameters of PBS and riboflavin in 479	
dextran at each depth interval. (B) Collagen fibril diameter distributions plotted as either 480	
uncorrected values from of riboflavin in dextran group (top panel, black filled squares), or 481	
corrected for dehydration (top panel, gray squares) or its corresponding PBS control (middle 482	
panel, blue filled squares). Traces are shown overlaid in bottom panels. Grey filled 483	
background added to aid visualization. (C) Collagen fibril diameter distribution curve of 484	
cross-linking group (green boxes) and its dextran control (black boxes) at each depth interval. 485	
(D) Relative collagen fibril diameter, (E) relative interfibrillar spacing, (F) relative collagen 486	
density of cross-linking group relative to its dextran group at each depth interval. Values are 487	
plotted as mean±SD from n=6 (A and B) or n=10 (C, D, E and F). Asterisks denote 488	
significant differences from control groups with * p < 0.05, ** p<0.01.  489	
 490	
Fig 5. Correlation between ultrastructural parameters and tangent modulus. Tangent 491	
modulus at 0.03MPa versus (A) collagen fibril diameter, (B) interfibrillar spacing and (C) 492	
collagen fibril density. Black boxes; dextran treated eyes, green boxes; 493	
Riboflavin+UVA+Dextran treated eyes, (D) percentage change in tangent modulus versus 494	
percentage change in each ultrastructural parameter. Each box represents the measurements 495	
from one eye for either fibril diameter (red), interfirbil distance (orange) or fibril density 496	
(yellow). (E) Percentage change in tangent modulus plotted against the cumulative effects of 497	
percentage change in fibril diameter+interfibril spacing-fibril density. Each box represents 498	
one eye. Green line; linear line of best fit. Red dotted line; 100% correlation. 499	
 500	
Fig 6. Absorption FTIR spectra of porcine corneas following cross-linking treatments. 501	
(A) Representative FTIR spectra of corneas treated with PBS (bottom, gray), 502	
riboflavin+dextran (middle, black) or riboflavin+dextran+UVA (top, green). (B) Regions 503	
where the characteristic bands are located shown at higher magnification and regions of 504	
interest indicated: Amide I (1,680–1,630 cm-1), Amide II (1570-1515 cm-1), Amide III 505	
(1,350–1,200 cm-1),	and CO absorption band (1,150–1,000 cm−1). (C) Relative intensity ratio 506	
of each characteristic band and (D) conversion rate of amide II to amide III.   507	
 508	
Fig 7. Proposed model of UVA/riboflavin cross-linking with the presence of dextran. The 509	
black solid circle, blue solid line, green solid line and red solid line represent the collagen 510	
molecules, proteoglycans, original cross-links formed between collagen molecules and 511	
additional cross-links induced by UVA/riboflavin cross-linking treatment, respectively. 512	
 513	
Supplementary Information Legends. 514	
S1 Fig.Transmission electron microscopy (TEM) images of porcine corneas imaged at 515	
different depth intervals following PBS, dextran and/or UVA/riboflavin treatment. 516	
Representative TEM images of PBS (A), Riboflavin+PBS (B), Riboflavin+Dextran (C), or 517	
Riboflavin+Dextran+UVA (D) and their corresponding controls at five depth intervals of 518	
0-50µm, 80-150µm, 200-250µm, 300-350µm, 400-450µm.  519	
 520	
S2 Fig. Collagen radius distribution of each treatment group at each depth intervals. The 521	
distribution of control segments (blue); (A) PBS, (D) PBS, (G) PBS, and (K) Dextran, and 522	
the experimental segments (orange) (B) PBS, (E) Riboflaivin+PBS, (H) Ribflavin+Dextran, 523	
and (L) Riboflaivn+Dextran+UVA. Dashed lines represent trend curves. The overlapped 524	
curves (C, F, I, J, M) were used for detecting the shifting of distribution in radius between 525	
control and experimental segments. The data were obtained at five depth intervals of 0-50µm, 526	
80-150µm, 200-250µm, 300-350µm, 400-450µm. p value of < 0.05 is indicated by an 527	
asterisk compared with its internal control. 528	
 529	
S1 Table. Summary of the average thickness and stiffening ratio at 0.03MPa of each group 530	
before and after thickness correction. Values denote mean ± standard deviation (SD). p value 531	
of < 0.05 is indicated by an asterisk compared with its control. Red asterisks indicate increase 532	
compared with control, green represents decrease. 533	
 534	
S2 Table. Mean diameter, interfibrillar spacing, and density of collagen fibrils of corneal 535	
segments at different depth intervals following PBS, dextran and/or UVA/riboflavin 536	
treatment. Values denote mean ± standard deviation (SD). p value of < 0.05 is indicated by an 537	
asterisk compared with its control. Red asterisks indicate increase compared with control, 538	
green represents decrease. 539	
 540	
S3 Table. Summary of area ratio corresponding to indicatged characteristic bands in FTIR 541	
spectra. Values denote mean ± standard deviation (SD). p value of < 0.05 is indicated by an 542	
asterisk compared with its control. Red asterisks indicate increase compared with control, 543	
green represents decrease. 544	
 545	
S4 Table. Parameters (decreased percentage, hydration loss percentage, remaining hydration 546	
percentage and swelling factor) used in correction of the collagen fibril radius distribution 547	
curves. 548	
 549	
